Chemotherapy-induced eccrine squamous syringometaplasia in an infant

被引：0
|
作者：
Bittar, Peter G. [1 ]
Casady, Megan [2 ]
Selim, Maria A. [2 ,3 ]
Prose, Neil S. [2 ]
机构：
[1] Duke Univ, Sch Med, Durham, NC USA
[2] Duke Univ, Med Ctr, Dept Dermatol, Durham, NC 27708 USA
[3] Duke Univ, Med Ctr, Pathol, Durham, NC USA
来源：
PEDIATRIC DERMATOLOGY | 2018年 / 35卷 / 01期
关键词：
chemotherapy; eccrine squamous syringometaplasia; infant;
D O I：
10.1111/pde.13360
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
There are few reports of chemotherapy-induced eccrine squamous syringometaplasia in children. We report the first case of an infant developing this condition after treatment with busulfan, fludarabine, and antithymocyte globulin in preparation for bone marrow transplantation. Twenty-eight days after transplantation, the infant developed faintly erythematous papules and plaques on the bilateral axillae, inguinal folds, and sites of adhesives. Punch biopsy revealed eccrine glands with dyskeratotic cells and focal squamous metaplasia consistent with chemotherapy-induced eccrine squamous syringometaplasia.
引用
收藏
页码：E84 / E85
页数：2
相关论文
共 50 条
  • [1] Chemotherapy-induced eccrine squamous syringometaplasia
    Khan, C.
    Byrne, N.
    Sheahan, K.
    Foley, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 126 - 126
  • [2] ECCRINE SQUAMOUS SYRINGOMETAPLASIA IN CHEMOTHERAPY-INDUCED ACRAL ERYTHEMA
    RONGIOLETTI, F
    REBORA, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (02) : 284 - 284
  • [3] Chemotherapy-induced eccrine squamous syringometaplasia - A distinctive eruption in patients receiving hematopoietic progenitor cells
    Valks, R
    Fraga, J
    PorrasLuque, J
    Figuera, A
    GarciaDiez, A
    FernandezHerrera, J
    ARCHIVES OF DERMATOLOGY, 1997, 133 (07) : 873 - 878
  • [4] ECCRINE SQUAMOUS SYRINGOMETAPLASIA FROM CHEMOTHERAPY EXTRAVASATION
    Bordel, Ma. Teresa
    Miranda, Alberto
    ACTAS DERMO-SIFILIOGRAFICAS, 2005, 96 (07): : 462 - 464
  • [5] Encorafenib-induced eccrine squamous syringometaplasia
    Potereau, A.
    Carmi, M.
    Luquet-Plantier, F.
    Gras, V.
    Baih, A. Id
    Dadban, A.
    Carmi, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2024, 151 (01):
  • [6] Olanzapine-Induced Eccrine Squamous Syringometaplasia
    Maria Molina-Ruiz, Ana
    Maria Molina-Ruiz, Rosa
    Zulueta, Teresa
    Barabash, Roman
    Requena, Luis
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2012, 34 (04) : 434 - 437
  • [7] Sorafenib-induced eccrine squamous syringometaplasia
    Velik, Charlotte
    De Rosa, Nicholas
    Kearney, Daniel
    Sidhu, Shireen
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (02) : E189 - E190
  • [8] Vemurafenib-Induced Eccrine Squamous Syringometaplasia
    Lescoat, A.
    Droitcourt, C.
    Stock, N.
    Le Gall, F.
    Dupuy, A.
    DERMATOLOGY, 2013, 226 (04) : 362 - 364
  • [9] Imatinib-induced eccrine squamous syringometaplasia
    Van de Voorde, Karen
    De Raeve, Hendrik
    Van Regenmortel, Niels
    Lambert, Julien
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (02) : S58 - S59
  • [10] Vincristine-induced Eccrine Squamous Syringometaplasia
    Thomas, Lacey Mitchell
    Mohr, Melinda
    Smith, Michael
    Boyd, Alan
    PEDIATRIC DERMATOLOGY, 2008, 25 (06) : 623 - 625
12345